Therapies at a glance
- Immunosuppressants: The active substance Sirolimus or Everolimus from the group of immunosuppressants is used, which slow down the activity of the immune system and in particular the proliferation of LAM cells. Sirolimus stabilizes lung function, alleviates breathing problems and ensures a better quality of life. However, when treatment is discontinued, the LAM progresses again. Sometimes we use bronchodilator medication (bronchodilators). They dilate the bronchial tubes and relieve shortness of breath.
- Oxygen therapy: In advanced LAM, oxygen therapy helps to compensate for the lack of oxygen. Those affected become physically fitter and more efficient again. Sometimes long-term treatment with oxygen is also necessary.
- Lung transplantation: This is an option if the lymphangioleiomyomatosis is very advanced. However, donor organs are in short supply in many countries, including Switzerland. As a result, many patients wait a long time for a new organ. Lung transplantation requires a good general condition and is more suitable for younger women. After a transplant, the prognosis is good – so far, specialists have not observed any relapses in which the tissue growths or tumors have returned.